Nucleus Biologics
PrivateCompany Overview
Nucleus Biologics is a biotechnology company that provides custom cell culture media, buffers, and reagents for the cell and gene therapy industry.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery, Pharma Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nucleus Biologics Comparables
Compare Nucleus Biologics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ampersand Capital Partners | 81% | |
| RoosterBio | 78% | |
| Shanghai BioEngine Sci-Tech Co., Ltd. | 78% | |
Nucleus Biologics Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 9, 2025
Monthly visitors grew 31% MoM, reaching 3.4K.
Nucleus Biologics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nucleus Biologics's valuation, stock price, and market status.